Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction [NA]

View source ↗

Summary

A clinical trial update describes a study evaluating liposomal amphotericin B for invasive aspergillosis in patients with hepatic dysfunction, with the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: Southeast University, China | Conditions: Aspergillosis Invasive | NA | Status: NOT_YET_RECRUITING